Acorah Software Products - Accounts Production19.3.600falsetruefalsetrueNo description of principal activity12 November 202430 November 202530 November 202516075233Mr D Smithiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure160752332024-11-11160752332025-11-30160752332024-11-122025-11-3016075233frs-core:CurrentFinancialInstruments2025-11-3016075233frs-bus:PrivateLimitedCompanyLtd2024-11-122025-11-3016075233frs-bus:FilletedAccounts2024-11-122025-11-3016075233frs-bus:Micro-entities2024-11-122025-11-3016075233frs-bus:AuditExempt-NoAccountantsReport2024-11-122025-11-3016075233frs-bus:Director12024-11-122025-11-30
Registered number: 16075233
Resurgence Psychotherapy Ltd
Unaudited Financial Statements
For the Period 12 November 2024 to 30 November 2025
Resurgence Psychotherapy Ltd
Balance Sheet
As At 30 November 2025
Balance Sheet
Registered number: 16075233
30 November 2025
£
Current assets
2,567
Creditors: Amounts Falling Due Within One Year
(1,652)
NET CURRENT ASSETS
915
TOTAL ASSETS LESS CURRENT LIABILITIES
915
Accruals and deferred income
(680)
NET ASSETS
235
CAPITAL AND RESERVES
235
Notes
1.General Information
Resurgence Psychotherapy Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16075233. The registered office is 21 Hill Street, Colne, BB8 0DH.
2.Average Number of Employees
Average number of employees, including directors, during the period was: 2
2
For the period ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.